The Creso Pharma [ASX:CPH] share price jumped 8% after completing the acquisition of Canadian psychedelics company Halucenex Life Sciences.
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
Trader’s Corner — Don’t Be Scared of Biotechs
In today’s Money Weekend…high risk for high reward…ignorance is bliss…a few biotech stocks for your watchlist…and more…
MGC Pharmaceuticals Share Price Up on CannEpil Update (ASX:MXC)
The MGC Pharmaceuticals [ASX:MXC] cannabis-derived epilepsy product is set to be fully covered by the HSE in Ireland.
Creso Share Price Soars on US Dual Listing (ASX:CPH)
The Creso Pharma Ltd [ASX:CPH] share price jumped 12% after the pot stock completed its US OTC dual listing. CPH shares were up as much as 15% in early trade…
Probiotec Shares Up As It Majorly Ups Guidance for FY21 (ASX:PBP)
Aspiring pill-packer Probiotec Ltd [ASX:PBP] share price is up 7.18% today, rising on the back of upgraded guidance from management…
Creso Share Price Up on Expanded Clinical Trial Plans (ASX:CPH)
The Creso Pharma [ASX:CPH] share price rose today after acquisition target Halucenex expands clinical trial recruitment.
